PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 141 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | -94.4% | 757 | -85.9% | 0.00% | – |
| Q2 2023 | $18 | -43.8% | 5,350 | -48.4% | 0.00% | – |
| Q1 2023 | $32 | -99.9% | 10,367 | -35.0% | 0.00% | – |
| Q3 2022 | $37,000 | +311.1% | 15,946 | +360.5% | 0.00% | – |
| Q2 2022 | $9,000 | -96.2% | 3,463 | -95.6% | 0.00% | – |
| Q4 2021 | $238,000 | +891.7% | 78,512 | +2871.7% | 0.00% | – |
| Q3 2021 | $24,000 | 0.0% | 2,642 | 0.0% | 0.00% | – |
| Q2 2021 | $24,000 | -79.7% | 2,642 | -81.2% | 0.00% | – |
| Q1 2020 | $118,000 | -81.2% | 14,039 | -80.4% | 0.00% | -100.0% |
| Q4 2019 | $626,000 | +1638.9% | 71,650 | +2003.0% | 0.00% | – |
| Q3 2019 | $36,000 | -78.3% | 3,407 | -74.0% | 0.00% | – |
| Q2 2019 | $166,000 | -46.6% | 13,123 | +63.4% | 0.00% | -100.0% |
| Q1 2019 | $311,000 | -55.9% | 8,031 | -76.9% | 0.00% | -50.0% |
| Q4 2018 | $706,000 | +132.2% | 34,716 | +423.5% | 0.00% | +100.0% |
| Q3 2018 | $304,000 | -72.4% | 6,632 | -64.4% | 0.00% | -75.0% |
| Q2 2018 | $1,101,000 | +228.7% | 18,629 | +448.7% | 0.00% | -71.4% |
| Q4 2017 | $335,000 | -74.0% | 3,395 | -77.0% | 0.01% | -75.0% |
| Q2 2017 | $1,289,000 | +522.7% | 14,757 | +163.9% | 0.06% | +522.2% |
| Q1 2017 | $207,000 | -81.7% | 5,591 | -67.0% | 0.01% | -88.3% |
| Q3 2016 | $1,134,000 | +368.6% | 16,918 | +107.6% | 0.08% | +381.2% |
| Q2 2016 | $242,000 | -34.2% | 8,148 | -35.1% | 0.02% | -44.8% |
| Q1 2016 | $368,000 | -60.9% | 12,558 | +4.7% | 0.03% | -60.8% |
| Q4 2015 | $940,000 | +27.2% | 11,991 | +22.2% | 0.07% | +37.0% |
| Q3 2015 | $739,000 | +31.5% | 9,810 | +103.8% | 0.05% | +14.9% |
| Q2 2015 | $562,000 | +39.8% | 4,814 | +182.5% | 0.05% | 0.0% |
| Q1 2015 | $402,000 | +91.4% | 1,704 | +53.7% | 0.05% | +88.0% |
| Q4 2014 | $210,000 | – | 1,109 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |